RCCD1

Across TCGA pan-cancer cohorts, RCCD1 Mutation is linked to patient survival in 7 of 34 cancer types, making it a survival-associated RCCD1 data layer compared with 25 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RCCD1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RCCD1 expression acts as an unfavorable survival marker.

LUSC, UCEC, and ESCA are the cancer types where RCCD1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	All	0.112	0.776	<.001	36	view →
UCEC	OS	Median	II,III,IV	0.231	0.768	.010	24	view →
ESCA	DFS	Median	II,III,IV	0.107	0.522	.012	12	view →
KIRC	OS	Median	All	0.140	0.628	.038	6	view →
BLCA	DFS	Median	All	0.096	0.626	<.001	6	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →
ACC	DFS	Median	All	0.195	0.748	.003	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RCCD1–LUSC (OS)

Open the LUSC breakdown →